SCHEMBL21450116

SCHEMBL21450116

CC(Cc1cccc(C(C)SS)n1)c1cncc(CC(C)c2cc[nH]n2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21675851 0.71 SLC6A4 (0.31) —
SCHEMBL21450061 0.70 ESR1 (0.39) —
SCHEMBL24700585 0.67 ALDH1A1 (0.34) —
SCHEMBL19954875 0.65 SMN1; SMN2 (0.38) —
SCHEMBL26399905 0.62 KCNH2 (0.31) —
SCHEMBL21085218 0.61 ALDH1A1 (0.33) —
SCHEMBL18427396 0.60 SMN1; SMN2 (0.38) —
SCHEMBL19646227 0.60 SMN1; SMN2 (0.38) —
SCHEMBL18811782 0.59 ESR1 (0.37) —
SCHEMBL22895111 0.59 NR3C2 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10752636-B2 HIV inhibitor compounds GILEAD SCIENCES, INC. (US) 2020-08-25 — — US disclosed
US-20190308983-A1 HIV INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. 2019-10-10 — — US disclosed
Send feedback